ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,061Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 1844

$628K Total Retail Price of All Prescriptions

Rank: 208 out of 1844

562 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 562 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

26% of this provider’s 562 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 9,360 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 757 424 S3 1 2
OMEPRAZOLE 529 317 2 5
FUROSEMIDE 386 309 3 7
AMLODIPINE BESYLATE 357 232 4 6
SIMVASTATIN 350 275 5 3
WARFARIN SODIUM 349 327 6 13
LEVOTHYROXINE SODIUM 323 298 7 1
LISINOPRIL 308 222 8 4
POTASSIUM CHLORIDE 288 219 9 16
METFORMIN HCL 256 181 10 8
HYDROCHLOROTHIAZIDE 215 164 11 9
METOPROLOL TARTRATE 184 145 12 11
TRAMADOL HCL 179 104 13 18
GLIMEPIRIDE 177 137 14 35
METOPROLOL SUCCINATE 171 141 15 14
ZOLPIDEM TARTRATE 163 92 16 23
CEFADROXIL 161 131 17 258
LOSARTAN POTASSIUM 155 128 18 24
CITALOPRAM HBR 154 77 19 19
CRESTOR 145 84 20 30
ALENDRONATE SODIUM 143 118 21 25
CLOPIDOGREL 135 103 22 34
TAMSULOSIN HCL 134 86 23 27
ATENOLOL 123 102 24 17
PANTOPRAZOLE SODIUM 121 104 25 32
RANITIDINE HCL 118 74 26 38
ALLOPURINOL 116 69 27 29
LOSARTAN-HYDROCHLOROTHIAZIDE 104 76 28 47
SERTRALINE HCL 102 73 29 21
AMOXICILLIN 102 87 29 101
PLAVIX 98 84 31 61
AZITHROMYCIN 98 66 31 37
KLOR-CON M20 97 92 33 54
MELOXICAM 83 61 34 28
GABAPENTIN 82 57 35 15
ESCITALOPRAM OXALATE 81 50 36 52
PREDNISONE 80 53 37 40
VENLAFAXINE HCL ER 77 35 38 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 67 39 20
SYNTHROID 76 76 39 55
PRAVASTATIN SODIUM 73 62 41 10
ROPINIROLE HCL 72 51 42 76
NEXIUM 69 51 43 31
IBUPROFEN 68 38 44 89
GEMFIBROZIL 66 56 45 108
ENALAPRIL MALEATE 64 52 46 69
CYMBALTA 63 53 47 36
ATORVASTATIN CALCIUM 62 52 48 12
DIOVAN 62 58 48 58
CLONIDINE HCL 62 49 48 64
DICLOFENAC SODIUM 62 38 48 122
CYCLOBENZAPRINE HCL 61 42 R 52 53
ISOSORBIDE MONONITRATE ER 60 39 53 59
POLYETHYLENE GLYCOL 3350 60 25 53 39
ZETIA 58 35 55 81
CIPROFLOXACIN HCL 58 36 55 62
TRIAMTERENE-HCTZ 56 55 57 48
SPIRIVA 56 45 57 57
VERAPAMIL ER 55 33 59 98
FLUOXETINE HCL 55 15 59 41
AMLODIPINE BESYLATE-BENAZEPRIL 54 45 61 80
SINGULAIR 53 28 62 102
OXYCODONE HCL-ACETAMINOPHEN 53 42 S2 62 83
DIGOXIN 52 46 64 67
BUPROPION XL 51 49 65 190
DIPHENOXYLATE-ATROPINE 50 35 66 291
DILTIAZEM 24HR CD 50 38 66 132
FLUCONAZOLE 50 20 66 187
DIOVAN HCT 50 41 66 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.